full issue - Association of Biotechnology and Pharmacy

More documents

Recommendations

Info

Current Trends in Biotechnology and PharmacyVol. 5 (1) 1043-1053 January 2011. ISSN 0973-8916 (Print), 2230-7303 (Online)1051compounds were practically proved as successfullead compounds and are continues to provide newbioactive products that lead to the discovery ofmany novel strains that produce useful secondarymetabolites. There is a broad range ofactinomycetes products such as antibiotics likestreptomycin and novobiocin are firmly cementedthese chemically prolific bacteria in the centrestage of natural products drug discovery research(21). The perspective of rapid emergence of drugresistance among bacterial pathogens shows thatthe potencies of prevalent antibiotics aredecreasing steadily, leading to reduced usefulperiod of drugs. This condition creates a demandfor the investigation of new, safe and effectiveantimicrobial compounds for replacement withexisting antimicrobials or use in antibiotic rotationprograms (22,23,24). In present studyStreptomyces represent a major portion ofactinomycetes in soil of Durg District ofChhattisgarh with significant biological activity.These isolates which show the both antibacterialand antifungal activity, may be produced either abroad spectrum antimicrobial compound or severalcompound with multitude of activity. The presentfinding highlighted the importance of work forfurther investigation towards the goal of obtaininga reliable methodology to isolate rare and unusualactinomycetes, to reduce the re-isolation of strainsproducing known bioactive compounds and toimprove the quality of natural products screenedisolated from Durg District of Chhattisgarh.INDIA.AcknowledgementAuthors are thankful to the School ofStudies in Life Sciences, Pt. Ravishankar ShuklaUniversity, Raipur, for providing lab facilities andfinancial support to carry out this work.References1. Kim, H.J., Lee, S.C. and Hwang, B.K.(2006) Streptomyces cheonanensis sp.nov., a novel Streptomycete with antifungalactivity. International Journal SystemEvolution Microbiology 56: 471-475.2. Watve, M.G., Tickoo, R., Jog, M.M. andBhole, B.D. (2001). How many antibioticsare produced by the genus Streptomyces?Archives Microbiology 176: 386-390.3. Lakshmipathy, D. and Kannabriran, K.(2010) Isolation and characterization ofantagonistic Actinomycetes from marinesoil. Journal of Microbial BiochemicalTechnology 2(1): 1-6.4. Labeda, D.P., Lechevalier, M.P. and Testa,R.T. (1997) Streptomyces stramineus sp.nov., a new species of the verticillateStreptomycetes. Integral Journal SystemBacteriology 47: 747–753.5. Dietera, A., Hamm, A., Fiedler, H.P., Muller,W.E.G., Brun, R., Beil, W., Kim, S.B. andGoodfellow, M. (2002) Streptomycesavermitilis sp. nov., nom. rev., a taxonomichome for the avermectin-producingStreptomycetes. International Journal ofSystem Evolution Microbiology 52: 2011–2014.6. Berdy, J. (2005) Bioactive microbialmetabolites. Journal of Antibiotics (Tokyo)58: 1–26.7. Saintpierre, D., Amir, H., Pineau, R.,Sembiring, L. and Goodfellow, M. (2003)Streptomyces yatensis sp. nov., a novelbioactive streptomycete isolated from aNew-Caledonian ultramafic soil. Antonievan Leeuwenhoek 83: 21–26.8. Huang, Y., Li, W., Wang, L., Lanoot, B.,Vancanneyt, M., Rodriguez, C., Liu, Z.,Swings, J. and Goodfellow, M. (2004)Streptomyces glauciniger sp. nov., a novelmesophilic streptomycete isolated from soilIsolation and Characterization of Streptomyces sp.
Current Trends in Biotechnology and PharmacyVol. 5 (1) 1043-1053 January 2011. ISSN 0973-8916 (Print), 2230-7303 (Online)1052in south China. International Journal ofSystem Evolution Microbiology 54: 2085–2089.9. Xu, C., Wang, L., Cui, Q., Huang, Y., Liu,Z., Zheng, G., and Goodfellow, M. (2006).Neutrotolerant acidophilic Streptomycesspecies isolated from acidic soils in China:Streptomyces guanduensis sp. nov.,Streptomyces paucisporeus sp. nov.,Streptomyces rubidus sp. nov. andStreptomyces yanglinensis sp. nov.International Journal of System EvolutionMicrobiology 56: 1109–1115.10. Newman, D.J., Cragg, G.M. and Snader,K.M. (2003). Natural products as a sourceof new drugs over the period 1981-2002. Adetailed analysis and description of currentnatural product derived therapeutic agents.Journal National Prod. 66: 1002-1037.11. Williams, S.T. and Davies, F.L. (1965) Useof antibiotics for selective isolation andenumeration of Actinomycetes in soil.Journal of General Microbiology 38: 251-261.12. Madigan, M.T., Martinko, J.M. and Parker,J. (1997) Antibiotics: isolation andcharacterization. In:Brock Biology ofMicroorganisms, 8th (eds), Prentice-HallInternational Inc. New Jersey, pp: 440-442.13. Grammer, A. (1976) Antibiotic sensitivity andassay test. In: Collins, C.H. and P.N. Lyne,editors. Microbiological Methods. London:Butterworths 23514. Shirling, E.B., and Gottieb, D. (1966)Methods, classification, identification anddescription of genera and species. TheWilliams and Wilkins Company, Baltimore,2: 61-292.15. Becker, B., Lechevalier, M.P., Gordon, R.E.and Lechevalier, H.A. (1964) Rapiddifferentiation between Nocardia andstreptomyces by paper chromatographywhole cell hydrolysates. AppliedMicrobiology 12: 421-423.16. Williams, S.T. Goodfellow, M. Alderson,G., Wellington, E.M., Sneath, P.H. andSackin, M.J. (1983) Numericalclassification of Streptomyces and relatedgenera. Journal of General Microbiology129: 1743-1813.17. Moncheva, P., Tishkov, S., Dimitrova, N.and Chipeva, V. (2002) Characteristics ofsoil actinomycetes from Antarctica. Journalof Culture Collection 3: 3-14.18. Augustine, S.K., Bhavasar, S.P. andKapadnis, B.P. (2005) Production of growthdependent metabolite active againstdermatophytes by Streptomyces rouchi AK39. Indian Journal of Medical Research 121:164-70.19. Mustafa, S.A., Tamer, U.A. and Azer, C.(2004) Antibacterial activity of someactinomycetes isolated from farming soil ofturkey. African Journal Biotechnology 3:441-446.20. Thakur, D., Mazumadar, S., Gogoi, D.K.and Bora, T.C. (2003) Isolation andscreening for biologically active metabolites.In: Bora, R.C. Unni, B. G. Deka, P. C. (Eds.),Bioprospecting of commercially importantplants. Proceedings National Symposium.ISAB-JC., 202-206.21. Jensen, P.R., Mincer, T.J. and Finical, W.(2003) The true potential of the marinemicroorganisms. Current Drug Discovery17-19.22. Gerding, D.N., Larson, T.A. and Hughes,R.A. (1991). Aminoglycoside resistanceand aminoglycoside usage: ten year ofSingh and Rai
Page 3 and 4:
ISSN 0973-8916Current Trends inBiot
Page 5 and 6:
Current Trends in Biotechnology and
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36: Current Trends in Biotechnology and
Page 85: Current Trends in Biotechnology and
Page 123: Current Trends in Biotechnology and
show all

full issue - Association of Biotechnology and Pharmacy

Create successful ePaper yourself

Delete template?

Save as template?